HEADER ANTIMICROBIAL PROTEIN 22-OCT-13 2MFS TITLE SOLUTION NMR STRUCTURE OF THE CACTUS-DERIVED ANTIMICROBIAL PEPTIDE EP- TITLE 2 AMP1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: EP-AMP1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC; SOURCE 4 ORGANISM_TAXID: 32630; SOURCE 5 OTHER_DETAILS: THIS PEPTIDE WAS ASSEMBLED USING STANDARD FMOC BASED SOURCE 6 SOLID PHASE PEPTIDE SYNTHESIS. KEYWDS CYSTINE-KNOT, ANTIMICROBIAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.ROSENGREN,U.GORANSSON,S.GUNASEKERA,T.L.ABOYE REVDAT 4 14-JUN-23 2MFS 1 REMARK REVDAT 3 06-MAY-15 2MFS 1 JRNL REVDAT 2 15-APR-15 2MFS 1 JRNL REVDAT 1 12-NOV-14 2MFS 0 JRNL AUTH T.L.ABOYE,A.A.STROMSTEDT,S.GUNASEKERA,J.G.BRUHN,H.EL-SEEDI, JRNL AUTH 2 K.J.ROSENGREN,U.GORANSSON JRNL TITL A CACTUS-DERIVED TOXIN-LIKE CYSTINE KNOT PEPTIDE WITH JRNL TITL 2 SELECTIVE ANTIMICROBIAL ACTIVITY. JRNL REF CHEMBIOCHEM V. 16 1068 2015 JRNL REFN ISSN 1439-4227 JRNL PMID 25821084 JRNL DOI 10.1002/CBIC.201402704 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TOPSPIN 2.1, CNS 1.2 REMARK 3 AUTHORS : BRUKER BIOSPIN (TOPSPIN), BRUNGER, ADAMS, CLORE, REMARK 3 GROS, NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SIMULATED ANNEALING FOLLOWED BY REMARK 3 REFINEMENT AND ENERGY MINIMIZATION IN EXPLICIT SOLVENT. REMARK 4 REMARK 4 2MFS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-NOV-13. REMARK 100 THE DEPOSITION ID IS D_1000103575. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.0 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 6 MG/ML EP-AMP1, 90% H2O/10% REMARK 210 D2O; 4 MG/ML EP-AMP1, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D DQF-COSY; 2D 1H-13C HSQC; 2D REMARK 210 1H-1H ECOSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 2.1, XEASY, CYANA 3.0, REMARK 210 CNS 1.2 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLN A 20 -68.10 -97.74 REMARK 500 4 PRO A 27 45.60 -74.38 REMARK 500 4 PHE A 28 -69.63 -148.98 REMARK 500 6 CYS A 23 98.10 -66.95 REMARK 500 6 PHE A 28 -60.51 -143.83 REMARK 500 9 PHE A 28 -63.54 -148.06 REMARK 500 10 SER A 18 86.54 -53.04 REMARK 500 10 PHE A 28 -66.90 -143.06 REMARK 500 11 SER A 18 99.00 -50.93 REMARK 500 12 PRO A 27 51.61 -63.42 REMARK 500 12 PHE A 28 -64.39 -144.34 REMARK 500 13 PRO A 27 49.66 -83.54 REMARK 500 13 PHE A 28 -77.59 -141.48 REMARK 500 14 SER A 18 99.23 -62.23 REMARK 500 15 ASP A 9 118.73 -161.86 REMARK 500 15 GLN A 20 52.19 -111.18 REMARK 500 15 PHE A 28 -87.51 -139.17 REMARK 500 16 SER A 18 107.75 -56.43 REMARK 500 16 PRO A 27 51.53 -64.29 REMARK 500 16 PHE A 28 -53.34 -139.16 REMARK 500 18 SER A 18 97.68 -68.66 REMARK 500 18 PRO A 27 42.86 -73.65 REMARK 500 18 PHE A 28 -67.65 -135.20 REMARK 500 19 SER A 18 96.60 -57.64 REMARK 500 19 CYS A 23 97.92 -68.13 REMARK 500 20 SER A 18 94.77 -58.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19570 RELATED DB: BMRB DBREF 2MFS A 1 35 PDB 2MFS 2MFS 1 35 SEQRES 1 A 35 CYS VAL LEU ILE GLY GLN ARG CYS ASP ASN ASP ARG GLY SEQRES 2 A 35 PRO ARG CYS CYS SER GLY GLN GLY ASN CYS VAL PRO LEU SEQRES 3 A 35 PRO PHE LEU GLY GLY VAL CYS ALA VAL SHEET 1 A 2 ASN A 22 LEU A 26 0 SHEET 2 A 2 GLY A 30 ALA A 34 -1 O VAL A 32 N VAL A 24 SSBOND 1 CYS A 1 CYS A 17 1555 1555 2.03 SSBOND 2 CYS A 8 CYS A 23 1555 1555 2.03 SSBOND 3 CYS A 16 CYS A 33 1555 1555 2.01 CISPEP 1 GLY A 13 PRO A 14 1 1.31 CISPEP 2 GLY A 13 PRO A 14 2 0.22 CISPEP 3 GLY A 13 PRO A 14 3 0.49 CISPEP 4 GLY A 13 PRO A 14 4 0.25 CISPEP 5 GLY A 13 PRO A 14 5 0.40 CISPEP 6 GLY A 13 PRO A 14 6 -1.18 CISPEP 7 GLY A 13 PRO A 14 7 1.52 CISPEP 8 GLY A 13 PRO A 14 8 0.43 CISPEP 9 GLY A 13 PRO A 14 9 0.31 CISPEP 10 GLY A 13 PRO A 14 10 0.27 CISPEP 11 GLY A 13 PRO A 14 11 -1.14 CISPEP 12 GLY A 13 PRO A 14 12 -0.87 CISPEP 13 GLY A 13 PRO A 14 13 1.28 CISPEP 14 GLY A 13 PRO A 14 14 -0.58 CISPEP 15 GLY A 13 PRO A 14 15 0.00 CISPEP 16 GLY A 13 PRO A 14 16 -0.22 CISPEP 17 GLY A 13 PRO A 14 17 -0.54 CISPEP 18 GLY A 13 PRO A 14 18 -0.61 CISPEP 19 GLY A 13 PRO A 14 19 0.57 CISPEP 20 GLY A 13 PRO A 14 20 -0.81 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1